Background
Mycoplasma hyopneumoniae and Porcine circovirus type 2 are two economically important pathogens affecting growing pigs. Control and prevention of both diseases can be accomplished by vaccination, together with biosecurity and good management practices. Many commercial vaccines are available. The aim of this study was to assess the efficacy of Hyogen® and Circovac® administered mixed at weaning and to compare this protocol with a competitor ready-to-use (RTU) vaccine.
Case presentation
A randomised field trial was designed in a commercial farrow-to-finish farm located in France. A total of 641 pigs born from 54 different sows were included in this study. Piglets at weaning were allocated into three groups: the first one vaccinated with Hyogen® and Circovac® combined (group A), the second one vaccinated with a competitor RTU vaccine (group B) and the last one unvaccinated. Only minor local reactions for both vaccination groups could be observed which revealed a good safety of both protocols. Both vaccination schemes in this trial didn’t improve wean-to-slaughter growth performances but significantly reduced lung lesions, lung fissures and pleurisy at slaughter, produced a seroconversion for both M. hyopneumoniae and PCV-2 and significantly reduced the PCV-2 viral load in blood. When we compared groups A and B, we observed no significant differences in growth performances, mortality, clinical signs, percentages of affected lungs at slaughter, lung fissures and pleurisy, and no difference in pathogens detection. However, two statistical differences were observed between both vaccines: the mean lung lesion score and the percentage of extensive lung lesions were lower in group A. This is consistent with lower M. hyopneumoniae loads in the lower respiratory tract in pigs from group A but this difference was not statistically significant.
Conclusions
Results reported in this case study must be considered with caution since it was done in only one farm. In this trial, Hyogen® and Circovac® mixed together under field conditions offered a successful protection of growing pigs and significantly decreased the extension of lung lesions during a natural field challenge when compared with a competitor RTU vaccine.
Background: Microbial colonisation of piglets' intestines starts at birth, especially from contact with sow's faeces. Piglet microbiota could therefore be influenced by the sow's diet. The objective of this study was to evaluate whether the microbiological flora of liquid feed for sows can be associated with the development of neonatal diarrhoea. Methods: This study was carried out on 10 case farms with neonatal diarrhoea and 10 control farms without neonatal diarrhoea. On each farm, a microbiological analysis of gestating and lactating liquid feed was performed. A generalised linear model was used to study the impact of the liquid feed microbiological counts and pH on the probability of neonatal diarrhoea developing. Results: For thermotolerant coliforms, sulphite-reducing bacteria, heterotrophic bacteria and lactic-acid bacteria counts, there was no significant difference between case and control farms. The higher the count of total coliforms, enterococci and yeasts in sow non-fermented liquid feed, the greater the probability of observing neonatal diarrhoea. Moreover, taking into account total coliforms and yeasts counts together is highly predictive of neonatal diarrhoea risk.
Conclusion:This study offers new perspectives of investigation and understanding of neonatal diarrhoea in breeding farms feeding sows with a nonfermented liquid feed.This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.